C12N 2320/10
In screening processes
Official title: in screening processes
C12N2320/10 (In screening processes) appears on 1,007 US grants and 2,218 published applications in this corpus.
Search patents in C12N- Granted patents
- 1,007
- Published applications
- 2,218
- Assignees
- 814
- Inventors
- 3,751
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 4 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 2 |
| 2003 | 1 | 15 |
| 2004 | 2 | 21 |
| 2005 | 1 | 47 |
| 2006 | 3 | 46 |
| 2007 | 3 | 96 |
| 2008 | 4 | 84 |
| 2009 | 41 | 99 |
| 2010 | 53 | 89 |
| 2011 | 41 | 78 |
| 2012 | 58 | 104 |
| 2013 | 57 | 83 |
| 2014 | 60 | 99 |
| 2015 | 57 | 109 |
| 2016 | 60 | 84 |
| 2017 | 68 | 83 |
| 2018 | 55 | 100 |
| 2019 | 54 | 104 |
| 2020 | 48 | 90 |
| 2021 | 72 | 114 |
| 2022 | 52 | 143 |
| 2023 | 60 | 150 |
| 2024 | 57 | 160 |
| 2025 | 51 | 132 |
| 2026 | 40 | 86 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Monocyte-specific aptamers and uses thereof for delivering therapeutic agents to heart11 Aug 2026US 12,702,716 B2Academia Sinica
- Small interfering RNA targeting C3 and uses thereof11 Aug 2026US 12,703,865 B2Sanegene Bio USA Inc.
- Methods and compositions for rapid direct detection and differentiation of infectious from noninfectious virus11 Aug 2026US 12,704,516 B2Consejo Nacional De Investigaciones Cientificas Y Tecnicas
- Isolated CAS13 protein and use thereof4 Aug 2026US 12,698,492 B2Guangzhou Reforgene Medicine Co., Ltd.
- Nucleic acid complexes for screening barcoded compounds28 Jul 2026US 12,692,491 B2Children's Medical Center Corporation
- Materials and methods for aptamer selection8 Oct 2026US 2026/0308599 A1The Penn State Research Foundation
- Electrochemical nucleic acid detection sensing element and electrochemical nucleic acid detection method based on rpa and crispr/cas24 Sep 2026US 2026/0287543 A1Institute of Process Engineering, Chinese Academy of Sciences
- Antisense oligomers for treatment of conditions and diseases17 Sep 2026US 2026/0275346 A1Stoke Therapeutics, Inc.
- Compositions and methods for the treatment of hemoglobinopathies10 Sep 2026US 2026/0265743 A1Intellia Therapeutics, Inc.
- Biomarkers10 Sep 2026US 2026/0266841 A1University of Warwick
Most cited
By later US patents
- CRISPR-Cas component systems, methods and compositions for sequence manipulation560US 8,795,965 B2Massachusetts Institute of Technology · 2014
- CRISPR-Cas component systems, methods and compositions for sequence manipulation529US 8,871,445 B2Massachusetts Institute of Technology · 2014
- Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation489US 8,865,406 B2Massachusetts Institute of Technology · 2014
- Engineering of systems, methods and optimized guide compositions for sequence manipulation480US 8,906,616 B2Massachusetts Institute of Technology · 2014
- Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation451US 8,889,418 B2Massachusetts Institute of Technology · 2014